← Leaderboards
Christopher P Larsen
Nephropathology Associates
$3,981,885
Attributed
$5,080,406
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2014–24$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,080,406 · 7
By mechanism
R44$3,875,830 · 2
R43$956,798 · 4
R41$247,778 · 1
Top collaborators
- Aaron Joseph Storey3 shared
Most similar at Nephropathology Associates
Same institution · by research overlap
- Aaron Joseph Storey$1,098,521
Others in their field
Top investigators on “Biopsy”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,871,847
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ralph Parchment · Leidos Biomedical Research, Inc.$43,674,966
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Peter Scott Heeger · Case Western Reserve University$37,822,090
Research focus
BiopsyLaboratoriesCostBaseKidneyDiagnosisSamplingSuccessProgramsProteinsReportingDiagnosticKidney DiseasesMass Spectrum AnalysisMembranous GlomerulonephritisTissuesValidationProteomicsKidney BiopsyNephrologyAntigensAutoantibodiesAutoantigensAffect
Grant awards (9)
A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases$950,283
R44 · FY2024 · DK · contact PI
A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases$976,283
R44 · FY2023 · DK · contact PI
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy$930,814
R44 · FY2023 · DK · contact PI
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy$1,018,450
R44 · FY2022 · DK · contact PI
Development of specific peptide reagents for serologic monitoring of Exostosin autoantibodies in membranous lupus nephritis$259,379
R43 · FY2022 · AR · contact PI
Rapid Genotyping of ApoL1 Risk Alleles using CRISPR-Cas12a$253,103
R43 · FY2021 · DK · contact PI
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy$247,778
R41 · FY2021 · DK · contact PI
Development of biomarkers for improved classification of membranous lupus nephritis$300,934
R43 · FY2019 · MD · contact PI
A Panel-Based Approach to the Diagnosis of Genetic Nephropathies Utilizing Next G$143,382
R43 · FY2014 · DK · contact PI